[1135] Sentinel Lymph Nodes and Vulvovaginal Melanoma: Comparison of Sentinel Lymph Node Protocols

Elizabeth D Euscher, Anais Malpica. University of Texas MD Anderson Cancer Center, Houston, TX

Background: Sentinel lymph node (SLN) biopsy is recommended for staging of patients (pts) with clinically node negative melanoma at any site; however, no universal pathology protocol for processing SLNs exists. Most centers utilize a combination of additional H&E levels (lev) and immunohistochemistry (IHC), but the number of and optimal distance between levels remain subject to debate. This study presents a single institution experience with two different SLN protocols in cases of vulvovaginal melanoma (VVM).
Design: From 1995-2012 30 pts with VVM underwent SLN biopsy. Pt age, follow up, tumor size, tumor thickness, presence/absence of lymphovascular invasion, number/status of SLN and non SLN and size of SLN metastases were recorded. Ultrastaging (US) was performed on 26 pts with negative SLN on the initial H&E slide: H&E lev only, 3 pts; 1H&E lev (at 4-16µ) with IHC, 17 pts; superficial lev (at 4-16µ) plus 4 additional H&E lev (250µ) with IHC, 6 pts; not performed, 2 early pts. To determine whether wide interval (WI) H&E lev plus IHC was superior to one H&E lev plus IHC, 4 additional WI at 250µ were cut in all cases without WI. IHC with a PanMel stain was performed in cases lacking IHC.
Results: Pts' ages ranged from 17-85 yr (62, median) with 5-149 months follow up (29, median) available for 27 pts: alive, 11 pts; alive with disease, 2 pts; dead of disease, 13 pts; dead unknown cause, 1 pts. Tumors (.55 to 5.0 cm; median 1.6 cm) ranged from .43-12.0 mm (2.0 mm, median) thick. 110 SLN were identified (1-11 SLN/pt). 10 pts (30%) had 15 positive (+)SLN. Initial H&E section detected 6 (+)SLNs. US detected 9 (+)SLN; one (+)SLN was seen on the second WI H&E slide. Metastasis size ranged from 2 cells to 14.0 mm. In 4/15 (27%) SLN, metastases were detected by IHC only. 17 pts had 99 non SLN identified, and 2 pts had (+) nonSLN. There were no false negative SLN. Table 1 contains clinicopathologic features of the 30 pts.

Clinicopathologic Features of Pts with SLN
FeaturePositive SLN (n=10)Negative SLN (n=20)
Median Age (yr)56.565.5
Follow up6/10 pts DOD7/20 pts DOD
Tumor thickness (mean, mm)3.25 ±3.353.17 ±3.17
Lymphovascular invasion present5/1010/20



Conclusions: An US protocol of 1 H&E lev and IHC improved detection of (+)SLN over one H&E slide (routine processing) alone (6/110, 5.45% vs 14/110, 12.72%). Additional WI H&E lev further increased detection of (+)SLN (15/110, 13.63%). Further study is required to determine whether the modest gain in (+)SLN detection of more comprehensive SLN protocols justifies increased time, labor and cost with respect to patient outcome.
Category: Gynecologic & Obstetrics

Tuesday, March 5, 2013 1:00 PM

Poster Session IV # 239, Tuesday Afternoon

 

Close Window